Vaxcyte (PCVX) Shares Issued (2019 - 2023)

Vaxcyte (PCVX) has 5 years of Shares Issued data on file, last reported at $4.6 million in Q4 2023.

• On a quarterly basis, Shares Issued fell 39.77% year-over-year to $4.6 million in Q4 2023; TTM through Dec 2023 was $4.6 million, a 39.77% decrease from a year earlier, with the FY2023 full-year figure at $4.6 million, down 39.77% from the prior year.
• Shares Issued for Q4 2023 stood at $4.6 million, up from $4.3 million in the prior quarter.
• Over the last five years, Shares Issued for PCVX reached as high as $9.1 million in Q1 2023 and fell as low as $650000.0 in Q2 2020.
• Historically, Shares Issued has averaged $4.3 million across 5 years, with a median of $4.6 million in 2020.
• Across the five-year window, Shares Issued jumped 547.69% in 2021 and sank 62.85% in 2022, its largest moves.
• Year by year, Shares Issued stood at $835941.0 in 2019, then surged by 456.4% to $4.7 million in 2020, then rose by 13.84% to $5.3 million in 2021, then soared by 45.71% to $7.7 million in 2022, then slumped by 39.77% to $4.6 million in 2023.
• Per Business Quant data, the three most recent Shares Issued figures were $4.6 million in Q4 2023, $4.3 million in Q3 2023, and $6.5 million in Q2 2023.